Recs

5

The Auction-Rate Thaw Turns to a Flood

Watch stocks you care about

The single, easiest way to keep track of all the stocks that matter...

Your own personalized stock watchlist!

It's a 100% FREE Motley Fool service...

Click Here Now

The next step in the auction-rate securities freeze-out is going to be the courtroom, and already the thaw is in full swing.

Auction-rate securities were originally marketed as being "as good as cash," but investors -- from big corporations like Palm (Nasdaq: PALM  ) , Bristol-Myers Squibb (NYSE: BMY  ) , and Bed Bath & Beyond (Nasdaq: BBBY  ) to little guys like my dentist -- found out the hard way that the only thing as good as cash is cash.

An auction-rate security is an investment whose interest rate resets every few weeks through periodic auctions. Until February, the market makers had never failed to find a buyer for these debts, but the dead of winter changed all that. With the credit markets in turmoil, no one wanted to touch this seemingly toxic paper -- and as quick as a flash-freeze, investors holding these securities were locked out of their money as surely as though it were buried three feet beneath the frozen tundra.

A thaw of sorts began last month, when Eaton Vance received regulatory approval to issue a new type of security that would begin to let investors access their money.

Then, last week, a flood of investment banks announced they were settling investigations by federal and state authorities into how they marketed these investments. Merrill Lynch (NYSE: MER  ) and Citigroup (NYSE: C  ) agreed to buy back $20 billion of auction-rate bonds from customers and pay a fine for their marketing practices. UBS (NYSE: UBS  ) agreed to buy back $19 billion by itself.

That's not enough for STMicroelectronics, which contends that Credit Suisse invested its money in auction-rate securities without authorization; ST has filed suit. Biovail did the same back in May, seeking tens of millions in compensatory and punitive damages through arbitration with the SEC.

That might be a little late for companies like Ciena (Nasdaq: CIEN  ) , Palm, and Bristol-Myers, which found profits hurt by the writedowns they had to take on the securities. It also comes too late for my dentist, who died of a heart attack a few weeks ago; at the time, he was dealing with an inability to get to his funds, which he needed to expand his practice.

The thaw is coming for those who can wait it out, but the repercussions will wash over the issuers who touted these investments that were supposedly “as good as cash” but weren't. For investors, let's hope the burned hand learns best -- and that the idea of chasing yield for a few extra points will be put on ice.

Open a cool one and read these related Foolish articles:

Best Odds in the Universe!
If you're interested in a 98.79% chance at beating the market... and a 70.84% chance at DOUBLING the market's return – Motley Fool Supernova could be just what you're looking for. And get this: We arrived at these odds from 10,000 random back-tested portfolios composed of Motley Fool Co-founder David Gardner's personal stock picks.

It's why David recently handpicked a small team of world-class portfolio managers. You see, he thinks these odds can get even better! And he'd like to prove it to you...

Simply enter your email address. And the answer to the question everybody is asking will be delivered to your inbox!

Bed Bath & Beyond is a Motley Fool Inside Value and a Motley Fool Stock Advisor pick. The Fool owns shares of Bed Bath & Beyond. Try any of our Foolish newsletters today, free for 30 days.

Fool contributor Rich Duprey owns shares of Bed Bath & Beyond but does not have a financial position in any of the other stocks mentioned in this article. You can see his holdings here. The Motley Fool has a disclosure policy.


Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

Fool Disclosure

DocumentId: 704636, ~/Articles/ArticleHandler.aspx, 2/14/2012 4:08:34 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated Moments ago Sponsored by:
DOW 12,878.28 4.24 0.03%
S&P 500 1,349.83 -1.94 -0.14%
NASD 2,927.23 -4.16 -0.14%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

2/14/2012 3:41 PM
BBBY $59.56 Up +0.19 +0.31%
Bed Bath & Beyond CAPS Rating: ***
MER $11.64 Down +0.00 +0.00%
Merrill Lynch & Co… CAPS Rating: *
PALM.DL $5.69 Down +0.00 +0.00%
Palm CAPS Rating: *
UBS $13.85 Down -0.33 -2.33%
UBS AG (USA) CAPS Rating: **
BMY $31.67 Down -0.32 -1.00%
Bristol-Myers Squi… CAPS Rating: ****
C $31.76 Down -1.12 -3.41%
Citigroup Inc CAPS Rating: ***
CIEN $16.81 Up +0.37 +2.25%
Ciena Corp CAPS Rating: **

Advertisement